Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS.

Freed TA, Coresh J, Inker LA, Toal DR, Perichon R, Chen J, Goodman KD, Zhang Q, Conner JK, Hauser DM, Vroom KET, Oyaski ML, Wulff JE, Eiríksdóttir G, Gudnason V, Torres VE, Ford LA, Levey AS.

Clin Chem. 2019 Mar;65(3):406-418. doi: 10.1373/clinchem.2018.288092. Epub 2019 Jan 15.

PMID:
30647123
2.

Identification of an Endogenous Organosulfur Metabolite by Interpretation of Mass Spectrometric Data.

Zhang Q, Ford LA, Evans AM, Toal DR.

Org Lett. 2018 Apr 6;20(7):2100-2103. doi: 10.1021/acs.orglett.8b00664. Epub 2018 Mar 26.

PMID:
29578721
3.

Structure elucidation of metabolite x17299 by interpretation of mass spectrometric data.

Zhang Q, Ford LA, Evans AM, Toal DR.

Metabolomics. 2017;13(8):92. doi: 10.1007/s11306-017-1231-x. Epub 2017 Jun 24.

4.

LC-MS/MS method for quantitation of seven biomarkers in human plasma for the assessment of insulin resistance and impaired glucose tolerance.

Zhang Q, Ford LA, Goodman KD, Freed TA, Hauser DM, Conner JK, Vroom KE, Toal DR.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 24. pii: S1570-0232(16)30598-0. doi: 10.1016/j.jchromb.2016.10.025. [Epub ahead of print]

PMID:
28029544
5.

A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia.

Griffiths EA, Brady WE, Tan W, Vigil CE, Thompson JE, Ford LA, Dickey NM, L Bashaw H, Sperrazza J, Wetzler M, Wang ES.

Leuk Res. 2016 Apr;43:44-8. doi: 10.1016/j.leukres.2016.02.003. Epub 2016 Feb 16.

PMID:
26943703
6.

Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.

Srivastava P, Paluch BE, Matsuzaki J, James SR, Collamat-Lai G, Blagitko-Dorfs N, Ford LA, Naqash R, Lübbert M, Karpf AR, Nemeth MJ, Griffiths EA.

Oncotarget. 2016 Mar 15;7(11):12840-56. doi: 10.18632/oncotarget.7326.

7.

Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia.

Muppidi MR, Portwood S, Griffiths EA, Thompson JE, Ford LA, Freyer CW, Wetzler M, Wang ES.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S73-9. doi: 10.1016/j.clml.2015.02.033.

PMID:
26297284
8.

Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old.

Gupta N, Miller A, Gandhi S, Ford LA, Vigil CE, Griffiths EA, Thompson JE, Wetzler M, Wang ES.

Am J Hematol. 2015 Jul;90(7):639-46. doi: 10.1002/ajh.24016.

9.

Metabolomics and its Application to the Development of Clinical Laboratory Tests for Prostate Cancer.

McDunn JE, Stirdivant SM, Ford LA, Wolfert RL.

EJIFCC. 2015 Mar 10;26(2):92-104. eCollection 2015 Mar.

10.

Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia.

Emadi A, Faramand R, Carter-Cooper B, Tolu S, Ford LA, Lapidus RG, Wetzler M, Wang ES, Etemadi A, Griffiths EA.

Am J Hematol. 2015 May;90(5):E77-9. doi: 10.1002/ajh.23965. Epub 2015 Feb 27.

11.

Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts.

Griffiths EA, Golding MC, Srivastava P, Povinelli BJ, James SR, Ford LA, Wetzler M, Wang ES, Nemeth MJ.

Haematologica. 2015 Feb;100(2):e49-52. doi: 10.3324/haematol.2014.113118. Epub 2014 Nov 7. No abstract available.

12.

Effects of the lapidus arthrodesis and chevron bunionectomy on plantar forefoot pressures.

King CM, Hamilton GA, Ford LA.

J Foot Ankle Surg. 2014 Jul-Aug;53(4):415-9. doi: 10.1053/j.jfas.2013.08.007.

PMID:
24958073
13.

Recruitment of PI4KIIIβ to coxsackievirus B3 replication organelles is independent of ACBD3, GBF1, and Arf1.

Dorobantu CM, van der Schaar HM, Ford LA, Strating JR, Ulferts R, Fang Y, Belov G, van Kuppeveld FJ.

J Virol. 2014 Mar;88(5):2725-36. doi: 10.1128/JVI.03650-13. Epub 2013 Dec 18.

14.

Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia.

Lee HJ, Muindi JR, Tan W, Hu Q, Wang D, Liu S, Wilding GE, Ford LA, Sait SN, Block AW, Adjei AA, Barcos M, Griffiths EA, Thompson JE, Wang ES, Johnson CS, Trump DL, Wetzler M.

Cancer. 2014 Feb 15;120(4):521-9. doi: 10.1002/cncr.28368. Epub 2013 Oct 25.

15.

Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age.

Vigil CE, Tan W, Deeb G, Sait SN, Block AW, Starostik P, Griffiths EA, Thompson JE, Greene JD, Ford LA, Wang ES, Wetzler M.

Leuk Res. 2013 Nov;37(11):1468-71. doi: 10.1016/j.leukres.2013.07.036. Epub 2013 Aug 15.

16.

Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia.

Wetzler M, Thomas DA, Wang ES, Shepard R, Ford LA, Heffner TL, Parekh S, Andreeff M, O'Brien S, Kantarjian HM.

Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):430-4. doi: 10.1016/j.clml.2013.03.015. Epub 2013 Jun 10.

17.

Increased long chain acyl-Coa synthetase activity and fatty acid import is linked to membrane synthesis for development of picornavirus replication organelles.

Nchoutmboube JA, Viktorova EG, Scott AJ, Ford LA, Pei Z, Watkins PA, Ernst RK, Belov GA.

PLoS Pathog. 2013;9(6):e1003401. doi: 10.1371/journal.ppat.1003401. Epub 2013 Jun 6.

18.

Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.

Al Ustwani O, Ford LA, Sait SJ, Block AM, Barcos M, Vigil CE, Griffiths EA, Thompson JE, Wang ES, Ambrus J Jr, Wetzler M.

Leuk Res. 2013 Aug;37(8):894-9. doi: 10.1016/j.leukres.2013.04.007. Epub 2013 May 18. Review.

19.

Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function.

Brady MT, Miller A, Sait SN, Ford LA, Minderman H, Wang ES, Lee KP, Baumann H, Wetzler M.

Leuk Res. 2013 Jul;37(7):822-8. doi: 10.1016/j.leukres.2013.04.002. Epub 2013 Apr 28.

20.

Association between ankle fractures and obesity.

King CM, Hamilton GA, Cobb M, Carpenter D, Ford LA.

J Foot Ankle Surg. 2012 Sep-Oct;51(5):543-7. doi: 10.1053/j.jfas.2012.05.016. Epub 2012 Jul 11.

PMID:
22789485
21.
22.

Complications associated with foot and ankle arthroscopy.

Deng DF, Hamilton GA, Lee M, Rush S, Ford LA, Patel S.

J Foot Ankle Surg. 2012 May-Jun;51(3):281-4. doi: 10.1053/j.jfas.2011.11.011. Epub 2011 Dec 20.

PMID:
22188904
23.

Is obesity a prognostic factor for acute myeloid leukemia outcome?

Lee HJ, Licht AS, Hyland AJ, Ford LA, Sait SN, Block AW, Barcos M, Baer MR, Wang ES, Wetzler M.

Ann Hematol. 2012 Mar;91(3):359-65. doi: 10.1007/s00277-011-1319-8. Epub 2011 Sep 21.

24.

Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia.

Wang ES, Zeidan A, Tan W, Wilding GE, Ford LA, Wallace PK, Hahn TE, Battiwalla M, McCarthy PL, Wetzler M.

Leuk Lymphoma. 2012 Oct;53(10):2085-8. doi: 10.3109/10428194.2011.603450. Epub 2011 Sep 6. No abstract available.

PMID:
21740302
25.

Smoking adversely affects survival in acute myeloid leukemia patients.

Varadarajan R, Licht AS, Hyland AJ, Ford LA, Sait SN, Block AW, Barcos M, Baer MR, Wang ES, Wetzler M.

Int J Cancer. 2012 Mar 15;130(6):1451-8. doi: 10.1002/ijc.26151. Epub 2011 Aug 2.

26.

Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia.

Wetzler M, Andrews C, Ford LA, Tighe S, Barcos M, Sait SN, Block AW, Nowak NJ, Baer MR, Wang ES, Baumann H.

Cancer. 2011 Nov 1;117(21):4861-8. doi: 10.1002/cncr.26097. Epub 2011 Mar 31.

27.

Radiographic outcomes of adult acquired flatfoot corrected by medial column arthrodesis with or without a medializing calcaneal osteotomy.

Jordan TH, Rush SM, Hamilton GA, Ford LA.

J Foot Ankle Surg. 2011 Mar-Apr;50(2):176-81. doi: 10.1053/j.jfas.2010.12.008.

PMID:
21354002
28.

Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia.

Deeb G, Vaughan MM, McInnis I, Ford LA, Sait SN, Starostik P, Wetzler M, Mashtare T, Wang ES.

Leuk Res. 2011 May;35(5):579-84. doi: 10.1016/j.leukres.2010.10.020. Epub 2010 Dec 21.

PMID:
21176961
29.

Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.

Wang ES, Sait SN, Gold D, Mashtare T, Starostik P, Ford LA, Wetzler M, Nowak NJ, Deeb G.

Cancer Genet Cytogenet. 2010 Oct 15;202(2):101-7. doi: 10.1016/j.cancergencyto.2010.07.117.

PMID:
20875872
30.

Myeloid blastic transformation of myeloproliferative neoplasms--a review of 112 cases.

Noor SJ, Tan W, Wilding GE, Ford LA, Barcos M, Sait SN, Block AW, Thompson JE, Wang ES, Wetzler M.

Leuk Res. 2011 May;35(5):608-13. doi: 10.1016/j.leukres.2010.07.031. Epub 2010 Aug 19. Review.

31.

A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.

Ford LA, Roelofs AJ, Anavi-Goffer S, Mowat L, Simpson DG, Irving AJ, Rogers MJ, Rajnicek AM, Ross RA.

Br J Pharmacol. 2010 Jun;160(3):762-71. doi: 10.1111/j.1476-5381.2010.00743.x.

32.
33.

Long-term safety and efficacy of cyclosporin A therapy for T-cell large granular lymphocyte leukemia.

Pawarode A, Wallace PK, Ford LA, Barcos M, Baer MR.

Leuk Lymphoma. 2010 Feb;51(2):338-41. doi: 10.3109/10428190903470851. No abstract available.

PMID:
20038217
34.

First metatarsophalangeal joint arthrodesis and revision arthrodesis.

Hamilton GA, Ford LA, Patel S.

Clin Podiatr Med Surg. 2009 Jul;26(3):459-73, Table of Contents. doi: 10.1016/j.cpm.2009.03.010.

PMID:
19505644
35.

Procedure selection for hallux valgus.

Ford LA, Hamilton GA.

Clin Podiatr Med Surg. 2009 Jul;26(3):395-407, Table of Contents. doi: 10.1016/j.cpm.2009.03.005.

PMID:
19505640
36.

The first ray is the major component of the medial column of the foot. Preface.

Ford LA.

Clin Podiatr Med Surg. 2009 Jul;26(3):xvii. doi: 10.1016/j.cpm.2009.04.004. No abstract available.

PMID:
19505635
37.

Cognitive-behavioural therapy for young children with anxiety disorders: Comparison of a Child + Parent condition versus a Parent Only condition.

Waters AM, Ford LA, Wharton TA, Cobham VE.

Behav Res Ther. 2009 Aug;47(8):654-62. doi: 10.1016/j.brat.2009.04.008. Epub 2009 May 7.

PMID:
19457471
38.

The effect of the Lapidus arthrodesis on the medial longitudinal arch: a radiographic review.

Avino A, Patel S, Hamilton GA, Ford LA.

J Foot Ankle Surg. 2008 Nov-Dec;47(6):510-4. doi: 10.1053/j.jfas.2008.06.008. Epub 2008 Jul 31.

PMID:
19239859
39.

The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.

Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, Irving AJ.

FASEB J. 2009 Jan;23(1):183-93. doi: 10.1096/fj.08-108670. Epub 2008 Aug 29.

PMID:
18757503
40.

Rates of revision surgery using Chevron-Austin osteotomy, Lapidus arthrodesis, and closing base wedge osteotomy for correction of hallux valgus deformity.

Lagaay PM, Hamilton GA, Ford LA, Williams ME, Rush SM, Schuberth JM.

J Foot Ankle Surg. 2008 Jul-Aug;47(4):267-72. doi: 10.1053/j.jfas.2008.03.002. Epub 2008 May 9.

PMID:
18590886
41.

Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members.

Padmanabhan A, Baker JA, Zirpoli G, Sait SN, Ford LA, Moysich KB, Baer MR.

Leuk Res. 2008 Dec;32(12):1820-3. doi: 10.1016/j.leukres.2008.03.032. Epub 2008 May 12.

PMID:
18468682
42.

Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia.

Burcu M, O'Loughlin KL, Ford LA, Baer MR.

Leukemia. 2008 Nov;22(11):2110-5. doi: 10.1038/leu.2008.87. Epub 2008 Apr 17. No abstract available.

PMID:
18418409
43.

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.

Arana-Yi C, Block AW, Sait SN, Ford LA, Barcos M, Baer MR.

Leuk Res. 2008 Jul;32(7):1043-8. Epub 2008 Feb 21.

PMID:
18093651
44.

Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia.

Weiss JR, Baer MR, Ambrosone CB, Blanco JG, Hutson A, Ford LA, Moysich KB.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):1038-41.

45.

The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells.

Brooks TA, O'Loughlin KL, Minderman H, Bundy BN, Ford LA, Vredenburg MR, Bernacki RJ, Priebe W, Baer MR.

Invest New Drugs. 2007 Apr;25(2):115-22. Epub 2006 Oct 28.

PMID:
17072745
46.
47.

Routine immunophenotyping in acute leukemia: Role in lineage assignment and reassignment.

Qadir M, Barcos M, Stewart CC, Sait SN, Ford LA, Baer MR.

Cytometry B Clin Cytom. 2006 Sep 15;70(5):329-34.

48.

Morbidity associated with high gastrocnemius recession: retrospective review of 126 cases.

Rush SM, Ford LA, Hamilton GA.

J Foot Ankle Surg. 2006 May-Jun;45(3):156-60.

PMID:
16651194
49.

Mortality and morbidity after transmetatarsal amputation: retrospective review of 101 cases.

Pollard J, Hamilton GA, Rush SM, Ford LA.

J Foot Ankle Surg. 2006 Mar-Apr;45(2):91-7.

PMID:
16513503
50.

Supplemental Content

Support Center